Vertex Pharmaceuticals Stock Soaring: Is More Upside Ahead?
Vertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
An overview of which total market fund performed best in 2024, with notes on expense, tracking error, and performance drivers.
28,518 articlesVertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
In the first five months of 2026, luxury buyer interest doubles in the U.S. luxury market, with buyers favoring large...
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
XRP has stabilized near $1.30, with a supply wall and on-chain behavior buffering downside. The piece breaks down wha...
Bitcoin steadies near $69,000 as oil spikes on Middle East tensions, marking a notable stress test for crypto's store...
BlinkEx rolls out early-access trading focused on robust infrastructure—fast matching, strong risk controls, and reli...
Ethereum failed to push above the $2.4K threshold, leaving the asset trapped in a tightening range as traders weigh d...
Bloom Energy stock reached a fresh intraday high as data-center demand and green-energy tech advances grab headlines....
A heated AI race has intensified as Google doubles down on AI integration amid OpenAI momentum. Critics raise a provo...
Dell Technologies shares have surged about 120% in a blistering run, pushing the stock toward record levels as AI inf...
Purchase applications rose 7% week over week and 17% year over year, even as mortgage rates hover near cycle highs. A...
Solana’s USDC mint collides with a DeFi shutdown as Drift recovery stalls; Pyra halts onboarding and preserves withdr...